tiprankstipranks

Kenneth Carl Anderson Insider Profile

4 Followers
Kenneth Carl Anderson, Director at C4 Therapeutics, holds 316.07K shares in C4 Therapeutics (Ticker: CCCC).
tipranks
Kenneth Carl Anderson

Kenneth Carl Anderson
C4 Therapeutics (CCCC)
Director

Ranked #93,279 out of 98,624 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-57.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Kenneth Carl Anderson's holdings

Insider Roles

C4 Therapeutics
(CCCC)
Director
Roles that Kenneth Carl Anderson holds in companies

Most Profitable Insider Trade

Stock:
C4 Therapeutics
(CCCC)
Rating:Informative Buy
Date:Jan 06, 2023 - Jan 06, 2024
Return:-4.70%
The most profitable trade made by Kenneth Carl Anderson

Kenneth Carl Anderson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
C4 Therapeutics
Apr 02, 2024
Director
Uninformative Buy
11.25K
$2.07M
Success Rate for
CCCC
0 out of 5 profitable transactions on
CCCC
0%
Average Return for
CCCC
Average return per transaction on
CCCC
-57.52%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 06, 2020
Uninformative Buy
$0.00
-
$0.00
Apr 06, 2021
Uninformative Buy
$8.74K
-
$37.51
Apr 14, 2021
Informative Buy
$2.77K
-
$3.90
-73.00%
Apr 14, 2021
Uninformative Buy
$0.00
-
$0.00
Jul 07, 2021
Uninformative Buy
$8.74K
-
$39.72
List of latest transactions for each holding click on a transaction to see Kenneth Carl Anderson's performance on stock

Kenneth Carl Anderson insider profile FAQ

What is the percentage of profitable transactions made by Kenneth Carl Anderson?
The percentage of profitable transactions made by Kenneth Carl Anderson is 0%.
    What is the average return per transaction made by Kenneth Carl Anderson?
    The average return per transaction made by Kenneth Carl Anderson is -57.50%.
      What stocks does Kenneth Carl Anderson hold?
      Kenneth Carl Anderson holds: CCCC stocks.
        What was Kenneth Carl Anderson’s latest transaction?
        Kenneth Carl Anderson latest transaction was an Uninformative Buy of $11.25K.
          What was Kenneth Carl Anderson's most profitable transaction?
          Kenneth Carl Anderson’s most profitable transaction was an Informative Buy of CCCC stock on January 6, 2023. The return on the trade was -4.70%.
            What is Kenneth Carl Anderson's role in C4 Therapeutics?
            Kenneth Carl Anderson's role in C4 Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.